Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma

NCT04088188 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma
Unresectable Cholangiocarcinoma

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Ivosidenib
DRUG: Pemigatinib

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]